JJ
Jennifer Jarrett bought $253K of DMRA stock
Jennifer Jarrett, Director, President and CEO of Damora Therapeutics, Inc. (DMRA), bought 12,500 shares of DMRA stock worth $253K, per an SEC Form 4 filed Sep 28, 2026.
It was an open-market purchase.
The trade happened on Sep 25, 2026, 3 days before it was made public.
DMRA has moved +4.5% since the trade date, from $20.66 to $21.60 (Nov 13, 2026 close).
- Traded
- Sep 25, 2026
- Disclosed
- Sep 28, 2026
- Filing delay
- 3 days
- Price since
- +4.5%
- Role
- Director, President and CEO
- Source
- SEC Form 4